Close Menu

Shanghai Jiao Tong University

In Genome Biology this week: pipeline to analyze pan-genome collections, method to examine rare cell types, and more.

A Chinese study involving NIPS data from almost two million pregnant women found that a new bioinformatic approach improves the detection of cancer.

By sequencing and characterizing the genome of Artemisia annua, researchers uncovered gene expansions and regulatory features linked to artemisinin production.

Research showed the gut microbiome of the giant panda is more similar to the microbiome of a carnivore and lacks bacteria needed to break down cellulose.

NEW YORK (GenomeWeb) – Researchers from China and the US used a combination of whole-exome sequencing and targeted gene sequencing to track down frequent mutations to the ErbB signaling pathway in gallbladder carcinoma tumors —

The goal of the partnership is to increase knowledge of the impact of ethnic diversity on the genetics of drug-induced serious adverse events.

By sequencing the exomes of a dozen acute myeloid leukemia samples from the M5 subtype and screening nearly 100 more, Chinese researchers have identified recurrent mutations in the DNA methyltransferase gene DNMT3A with potential ties to patient outcomes.

Zhimin Wang, a professor in the School of Agriculture and Biology at Shanghai Jiao Tong University in China, is working on a sequencing approach that uses an exonuclease to cleave off single nucleotides from a DNA molecule and detects them by one of two different types of sensors.

Patent awarded to Shanghai Jiao Tong University.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.